ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      5,722.26
      -0.19%
      US Tech 100
      19,430.00
      0.08%
      Dow Jones
      41,914.75
      -0.70%
      Brent Oil
      73.085
      -1.98%
      Bitcoin
      63,352.81
      -1.43%
      Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. AMEX
      6. NovaBay Pharmaceuticals Inc New (NBY)

      7. NovaBay Pharmaceuticals Inc New (NBY) News

      NBY

      NovaBay Pharmaceuticals (NBY)

      NovaBay Pharmaceuticals Inc New
      		Date:
      Sort by:
       Showing the most relevant articles for your search:AMEX:NBY
      DateTimeSourceHeadlineSymbolCompany
      09/23/20249:27AMPR Newswire (US)Kuehn Law Encourages COFS, ARC, RFL, and NBY Investors to Contact Law FirmAMEX:NBYNovaBay Pharmaceuticals Inc New
      09/20/20248:30AMPR Newswire (US)Acumen Health Holdings ("Acumen") to Acquire the Avenova brand from NovaBay PharmaceuticalsAMEX:NBYNovaBay Pharmaceuticals Inc New
      09/20/20248:08AMEdgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialAMEX:NBYNovaBay Pharmaceuticals Inc New
      09/20/20248:08AMEdgar (US Regulatory)Form 8-K - Current reportAMEX:NBYNovaBay Pharmaceuticals Inc New
      09/20/20248:00AMBusiness WireNovaBay Pharmaceuticals Signs Definitive Agreement to Sell its Avenova AssetsAMEX:NBYNovaBay Pharmaceuticals Inc New
      08/13/20244:11PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]AMEX:NBYNovaBay Pharmaceuticals Inc New
      08/13/20244:05PMBusiness WireNovaBay Pharmaceuticals Reports Second Quarter 2024 Financial ResultsAMEX:NBYNovaBay Pharmaceuticals Inc New
      08/01/20246:50AMBusiness WireNovaBay Pharmaceuticals to Hold Second Quarter 2024 Conference Call on August 13, 2024AMEX:NBYNovaBay Pharmaceuticals Inc New
      07/30/20246:50AMBusiness WireNovaBay Pharmaceuticals Reports Record Amazon Prime Day SalesAMEX:NBYNovaBay Pharmaceuticals Inc New
      07/29/20244:25PMEdgar (US Regulatory)Form 8-K - Current reportAMEX:NBYNovaBay Pharmaceuticals Inc New
      07/29/20244:05PMBusiness WireNovaBay Pharmaceuticals Announces Closing of $3.87 Million Underwritten Public Offering, Including Partial Exercise of Overallotment OptionAMEX:NBYNovaBay Pharmaceuticals Inc New
      07/26/20245:19PMEdgar (US Regulatory)Form POS EX - Post-effective amendment adding exhibits to registration statement [Rule 462(d)]AMEX:NBYNovaBay Pharmaceuticals Inc New
      07/26/20248:30AMBusiness WireNovaBay Pharmaceuticals Announces Pricing of $3.5 Million Underwritten Public OfferingAMEX:NBYNovaBay Pharmaceuticals Inc New
      07/26/202412:15AMEdgar (US Regulatory)Form EFFECT - Notice of EffectivenessAMEX:NBYNovaBay Pharmaceuticals Inc New
      07/16/20246:50AMBusiness WireNovaBay Pharmaceuticals Offers 20% Discounts on Avenova Eyecare Products During Amazon Prime DayAMEX:NBYNovaBay Pharmaceuticals Inc New
      07/11/20248:50AMEdgar (US Regulatory)Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectusesAMEX:NBYNovaBay Pharmaceuticals Inc New
      07/11/20248:45AMEdgar (US Regulatory)Form 8-K - Current reportAMEX:NBYNovaBay Pharmaceuticals Inc New
      07/11/20246:50AMBusiness WireNovaBay Pharmaceuticals Reports Preliminary Second Quarter 2024 Net Revenue of $2.4 MillionAMEX:NBYNovaBay Pharmaceuticals Inc New
      07/10/20244:05PMEdgar (US Regulatory)Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectusesAMEX:NBYNovaBay Pharmaceuticals Inc New
      07/10/20249:30AMEdgar (US Regulatory)Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]AMEX:NBYNovaBay Pharmaceuticals Inc New
      06/28/20246:50AMBusiness WireNovaBay Pharmaceuticals Supports National Dry Eye Awareness Month with Multiple Avenova Product PromotionsAMEX:NBYNovaBay Pharmaceuticals Inc New
      06/14/20248:47AMEdgar (US Regulatory)Form 8-K - Current reportAMEX:NBYNovaBay Pharmaceuticals Inc New
      06/07/20247:30AMEdgar (US Regulatory)Form 8-K - Current reportAMEX:NBYNovaBay Pharmaceuticals Inc New
      06/07/20246:50AMBusiness WireNovaBay Pharmaceuticals Plan of Compliance Accepted by the NYSE AmericanAMEX:NBYNovaBay Pharmaceuticals Inc New
      05/31/20244:50PMEdgar (US Regulatory)Form 8-K - Current reportAMEX:NBYNovaBay Pharmaceuticals Inc New
      05/31/20244:43PMEdgar (US Regulatory)Form 8-K/A - Current report: [Amend]AMEX:NBYNovaBay Pharmaceuticals Inc New
      05/30/20249:31PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesAMEX:NBYNovaBay Pharmaceuticals Inc New
      05/30/20249:29PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesAMEX:NBYNovaBay Pharmaceuticals Inc New
      05/30/20249:27PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesAMEX:NBYNovaBay Pharmaceuticals Inc New
      05/30/20249:24PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesAMEX:NBYNovaBay Pharmaceuticals Inc New
       Showing the most relevant articles for your search:AMEX:NBY